Voglitor MD 0.3mg Tablet
Torrent Pharmaceuticals Ltd

prescription required

Bookmark
In-stock 10 tablet md in 1 strip
221.25

NOTICE: unsafe with : Alcohol

USED FOR:
Type 2 diabetes

COMPOSITION:
Voglibose (0.3mg)

Therapeutic Uses:
anti diabetic

Related Warnings
CAUTION
Alcohol
CAUTION

Taking Voglibose with alcohol reduce the blood sugar levels in diabetic patients.

PROBABLY SAFE
Pregnancy
PROBABLY SAFE

Voglitor MD 0.3mg Tablet is probably safe to use during pregnancy.Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.

Lactation

Voglitor MD 0.3mg Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.

SAFE
Driving
SAFE

Voglitor MD 0.3mg Tablet does not usually affect your ability to drive.

Kidney

Voglitor MD 0.3mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Voglitor MD 0.3mg Tablet may be needed. Please consult your doctor.

Liver

There is limited information available on the use of Voglitor MD 0.3mg Tablet in patients with liver disease. Please consult your doctor.

Voglibose   0.3mg

Uses of Voglitor Tablet MD
Voglitor MD 0.3mg Tablet is used in the treatment of type 2 diabetesIt is used in addition to diet and exercise to improve blood sugar control in adults with type 2 diabetes.

How to use Voglitor Tablet MD
Take this medicine in the dose and duration as advised by your doctor. Do not handle the tablets with wet hands. Put it in your mouth but do not swallow it. Voglitor MD 0.3mg Tablet is to be taken with food.

How Voglitor Tablet MD works
Voglitor MD 0.3mg Tablet is an anti-diabetic medication. It inhibits the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.

Side Effects:

Common Skin rash, Flatulence, Abdominal pain, Diarrhoea.

Expert advice for Voglitor Tablet MD
Voglitor is used together with other diabetes medicines to control blood sugar and avoids long-term complications. You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Voglitor. Voglitor lowers your post-meal blood sugar levels, and therefore should be taken just before meals. Side effects such as stomach pain, gas, and diarrhoea may occur during the first few weeks of treatment but should get better with time.

Frequently Asked Questions

Q. Can I use Voglitor for weight loss?
No. Voglitor is not approved for weight loss. It can produce weight loss on prolonged use due to inhibition of carbohydrate digestion and delayed gastric emptying. It is used in the treatment of type 2 diabetes mellitus with post-prandial hyperglycemia.

Q. Voglitor should not be used in which condition?
Voglitor should not be used in patients with inflammatory bowel disease, colonic ulceration, intestinal obstruction, or chronic intestinal disease and in patients with severe hepatic impairment.

Q. Can I use Voglitor with insulin?
Yes. Voglitor can be used along with Insulin. It may potentiate the hypoglycemic effects of insulin, so the dosages of these agents may need to be changed accordingly.

Q. What would be the benefit to taking Pioglitazone vs Voglitor?
Pioglitazone gives a better control of blood sugar as compared to Voglitor.

Q. Which class of drug Voglitor belongs?
Voglitor belongs to the class of drug known as an alpha-glucosidase inhibitor.

Q. How to use Voglitor?
Voglitor are taken orally and should be chewed with the first mouthful of food, or swallowed whole with a little liquid directly before the meal. It is only effective in patients eating complex carbohydrates as they delay glucose absorption until further along the digestive tract.

Q. Why is Voglitor safer than acarbose?
Voglitor has less chance of causing flatulence and gastrointestinal side effects than acarbose.

Q. Can I take Voglitor and metformin in combination?
Yes. Voglitor can be taken with metformin.